Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Millennium:The Takeda Oncology Company (formerlyMillennium Pharmaceuticals, Inc.
Lobbying Relationship
Bills mentioned
H.R.3590: Patient Protection and Affordable Care Act
Sponsor: Charles B. Rangel (D-N.Y.)
H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...
Sponsor: John D. Dingell (D-Mich.)
S.1679: Affordable Health Choices Act
Sponsor: Tom Harkin (D-Iowa)
H.R.3200: America's Affordable Health Choices Act of 2009
Sponsor: John D. Dingell (D-Mich.)
S.717: 21st Century Cancer ALERT (Access to Life-Saving Early detection,...
Sponsor: Edward M. Kennedy (D-Mass.)
S.2499: Medicare, Medicaid, and SCHIP Extension Act of 2007
Sponsor: Max Baucus (D-Mont.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| John Green | Dep Chief of Staff/ Leg Aide, Sen Trent Lott |
| Andrew Rosenberg | n/a |
| Gordon Taylor | n/a |
| Moses Mercado | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate